China vs Gabon: HIV-positive TB patients on ART (antiretroviral therapy)
China
85.0%
in 2024
Gabon
85.0%
in 2024
China rank
106th
Gabon rank
106th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- China
- Gabon
How they compare
China currently reports 85.0% against 85.0% in Gabon, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2008 it was Gabon ahead.
China ranks 106th and Gabon ranks 106th of 144 countries.
Across the 3 decades both report, China averaged higher in 1 and Gabon in 1.
Head to head by decade
| Decade | China | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.5% | 50.5% | 19.0% | Gabon |
| 2010s | 66.4% | 66.4% | 0.0% | — |
| 2020s | 81.2% | 76.2% | 5.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), China or Gabon?
- China, at 85.0% against 85.0% in Gabon as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between China and Gabon?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Gabon?
- 14 years are reported by both, from 2008 to 2024.
- How do China and Gabon rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- China ranks 106th and Gabon ranks 106th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.